Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. / Thomsen, L L; Iversen, Helle Klingenberg; Brinck, T A; Olesen, J.
I: Cephalalgia : an international journal of headache, Bind 13, Nr. 6, 12.1993, s. 395-9; discussion 376.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers
AU - Thomsen, L L
AU - Iversen, Helle Klingenberg
AU - Brinck, T A
AU - Olesen, J
PY - 1993/12
Y1 - 1993/12
N2 - The sensitivity to nitroglycerin-induced dilatation of large intracranial arteries was studied in 17 patients with migraine without aura, 17 age and sex-matched healthy subjects and 9 patients with episodic tension-type headache. Nitroglycerin in the doses of 0.015, 0.03, 0.25 microgram/kg/min was successively infused for 15 min per dose. Blood velocity (Vmean) in the middle cerebral artery (MCA) was recorded with transcranial Doppler before and at the end of every infusion period, and 30 and 60 min after end of the last infusion. In all three groups Vmean decreased with increasing doses (p < 0.001). The response was more pronounced in migraine patients at the two higher doses (p < 0.05). Since nitroglycerin acts as an exogenous source of nitric oxide (NO), these data support that NO supersensitivity may be an important molecular mechanism of migraine pain.
AB - The sensitivity to nitroglycerin-induced dilatation of large intracranial arteries was studied in 17 patients with migraine without aura, 17 age and sex-matched healthy subjects and 9 patients with episodic tension-type headache. Nitroglycerin in the doses of 0.015, 0.03, 0.25 microgram/kg/min was successively infused for 15 min per dose. Blood velocity (Vmean) in the middle cerebral artery (MCA) was recorded with transcranial Doppler before and at the end of every infusion period, and 30 and 60 min after end of the last infusion. In all three groups Vmean decreased with increasing doses (p < 0.001). The response was more pronounced in migraine patients at the two higher doses (p < 0.05). Since nitroglycerin acts as an exogenous source of nitric oxide (NO), these data support that NO supersensitivity may be an important molecular mechanism of migraine pain.
KW - Adult
KW - Analysis of Variance
KW - Cerebral Arteries
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Migraine Disorders
KW - Nitric Oxide
KW - Nitroglycerin
KW - Ultrasonography, Doppler, Transcranial
KW - Vasodilation
M3 - Journal article
C2 - 7906202
VL - 13
SP - 395-9; discussion 376
JO - Cephalalgia
JF - Cephalalgia
SN - 0800-1952
IS - 6
ER -
ID: 128984494